Renal Cell Carcinoma Associated With Renal Angiomyolipomas
In this diagnostically challenging case, a 13-year-old patient presented with a rare combination of angiomyolipomas, renal cell carcinoma, and pulmonary nodules. What was the connection?
FDA Approves Everolimus for Renal Angiomyolipomas - Medscape
Apr 26, 2012 · The FDA has approved mTor inhibitor everolimus for the treatment of renal angiomyolipomas not requiring immediate surgery in patients with tuberous sclerosis complex.
CMS Coverage May Boost Uptake of Renal Denervation - Medscape
Dec 2, 2025 · The CMS decision to cover renal denervation for uncontrolled hypertension may help overcome current hesitation about use of the procedure.
ImmunoPET Tracer Can Detect Common Kidney Cancers - Medscape
PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies and surgeries.
Got Milk? It’s a Tricky Question for Renal Patients - Medscape
Dec 17, 2025 · Renal diets with limits on protein, potassium, phosphorus, calcium, and sodium make milk choices baffling. Knowing the pros and cons of a variety of milks can help take the …
Key Advances in Hypertension From ACC 2025 - Medscape
Apr 21, 2025 · Advances in hypertension as reported at ACC 2025 include two new therapies that achieve significant blood pressure (BP) reduction, and a comparison of renal denervation …
Medscape | Nippon Hinyokika Gakkai Zasshi - Content Listing
Jan 1, 2017 · 2017 - 108 (2) [HUGE RENAL ANGIOMYOLIPOMA COMPLICATED WITH COMMON ILIAC VEIN THROMBUS BECAUSE OF THE TUMOR PRESSURE]. January 01, …
Diagnosis and Management of Benign Liver Tumors - Page 2
Less Common Solid Benign Liver Tumors An angiomyolipoma is a very rare hepatic tumor consisting of fat, epithelioid, and smooth muscle cells with thick-walled blood vessels.
SGLT2 Inhibitors Can Modulate Adiposopathy in CKD - Medscape
5 days ago · The use of SGLT2 inhibitors, especially dapagliflozin, can lower adiposopathy parameters in patients with CKD, regardless of diabetes status, a cohort study finds.
Immune Status Does Not Affect Thyroid Cancer Prognosis
Dec 2, 2025 · Differentiated thyroid cancer shows a comparable prognosis in patients with immunocompromised vs immunocompetent status, a recent study reveals.